Govt move of taxing life-saving drugs may boost domestic cos

Indian drug associations say that this hike, which is essentially a withdrawal of exemptions, will have a marginal impact on prices.

February 09, 2016 / 21:50 IST

The Indian pharma sector is split down the middle on the government's decision to hike customs duty on 76 life-saving drugs. While many companies slammed the hike in duties, quiet a few say the hike will not result in a rise in drug prices and their own counterparts in the industry say this is a knee-jerk reaction. Indian drug associations say that this hike, which is essentially a withdrawal of exemptions, will have a marginal impact on prices. CNBC-TV18's Archana Shukla explores this contrarian view.Watch video for more

first published: Feb 9, 2016 09:50 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347